1. Home
  2. LGVN vs NWGL Comparison

LGVN vs NWGL Comparison

Compare LGVN & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • NWGL
  • Stock Information
  • Founded
  • LGVN 2014
  • NWGL 2008
  • Country
  • LGVN United States
  • NWGL Macau
  • Employees
  • LGVN N/A
  • NWGL N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • NWGL
  • Sector
  • LGVN Health Care
  • NWGL
  • Exchange
  • LGVN Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • LGVN 23.4M
  • NWGL 26.2M
  • IPO Year
  • LGVN 2021
  • NWGL 2023
  • Fundamental
  • Price
  • LGVN $1.30
  • NWGL $1.11
  • Analyst Decision
  • LGVN Strong Buy
  • NWGL
  • Analyst Count
  • LGVN 3
  • NWGL 0
  • Target Price
  • LGVN $8.67
  • NWGL N/A
  • AVG Volume (30 Days)
  • LGVN 138.8K
  • NWGL 922.8K
  • Earning Date
  • LGVN 08-13-2025
  • NWGL 07-07-2025
  • Dividend Yield
  • LGVN N/A
  • NWGL N/A
  • EPS Growth
  • LGVN N/A
  • NWGL N/A
  • EPS
  • LGVN N/A
  • NWGL N/A
  • Revenue
  • LGVN $2,225,000.00
  • NWGL $21,539,347.00
  • Revenue This Year
  • LGVN N/A
  • NWGL N/A
  • Revenue Next Year
  • LGVN $51.48
  • NWGL N/A
  • P/E Ratio
  • LGVN N/A
  • NWGL N/A
  • Revenue Growth
  • LGVN 127.50
  • NWGL N/A
  • 52 Week Low
  • LGVN $1.14
  • NWGL $0.95
  • 52 Week High
  • LGVN $6.40
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 50.13
  • NWGL 45.23
  • Support Level
  • LGVN $1.15
  • NWGL $1.32
  • Resistance Level
  • LGVN $1.32
  • NWGL $6.61
  • Average True Range (ATR)
  • LGVN 0.09
  • NWGL 0.61
  • MACD
  • LGVN 0.01
  • NWGL -0.10
  • Stochastic Oscillator
  • LGVN 45.31
  • NWGL 2.83

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: